Cellebrite hits record $481M ARR as drone forensics M&A fuels AI pivot
Cellebrite (NASDAQ:CLBT) delivered record fourth-quarter and full-year 2025 results, signaling a successful transition from a hardware-centric forensics provider to a high-margin, AI-powered software platform.











